Decrease in the Expression of a Novel TGF Beta1-inducible and Ras-recision Gene, TSC-36, in Human Cancer Cells
Overview
Affiliations
TSC-36, a TGF beta1-inducible gene, encodes a polypeptide that shows significant similarity to SPARC (secreted protein rich in cysteine), and follistatin, an activin-binding protein. The expression of the TSC-36 gene was reported to be extinguished in v-ras-transformed mouse fibroblastic cells, and also was found also to be abrogated in cells transformed with v-myc. The level of expression was, however, not affected in cells transformed with v-src, v-abl, or v-raf. The TSC-36 cDNA was first isolated from mouse cells, and recently its rat and human homologues have been reported which show striking similarity with each other. In various human tumor cells, TSC-36 mRNA was almost undetectable. TSC-36 mRNA was detected in various mouse organs, but its level was the highest in the lung. TSC-36 mRNA level was the highest in the lung among mouse organs, and on in situ hybridization, the TSC-36 transcript was detected in the alveolar epithelium but not in the bronchial epithelium. These features suggest possible usage of TSC-36 as one of the markers in human tumors.
The BMP inhibitor follistatin-like 1 (FSTL1) suppresses cervical carcinogenesis.
Zhao C, Chen Z, Zhu L, Miao Y, Guo J, Yuan Z Front Oncol. 2023; 13:1100045.
PMID: 36756161 PMC: 9901576. DOI: 10.3389/fonc.2023.1100045.
Zhao Y, Ou Q, Deng Y, Peng J, Li C, Li J Ann Transl Med. 2020; 7(21):606.
PMID: 32047767 PMC: 7011597. DOI: 10.21037/atm.2019.09.20.
Structural and functional study of FK domain of Fstl1.
Li X, Li L, Chang Y, Ning W, Liu X Protein Sci. 2019; 28(10):1819-1829.
PMID: 31351024 PMC: 6739823. DOI: 10.1002/pro.3696.
Follistatin-like 1 in development and human diseases.
Mattiotti A, Prakash S, Barnett P, van den Hoff M Cell Mol Life Sci. 2018; 75(13):2339-2354.
PMID: 29594389 PMC: 5986856. DOI: 10.1007/s00018-018-2805-0.
FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
Ni X, Cao X, Wu Y, Wu J Oncol Rep. 2017; 39(1):13-20.
PMID: 29115636 PMC: 5783594. DOI: 10.3892/or.2017.6061.